STAR

HealthcareDrug Manufacturers - Specialty & GenericMid Cap
Strides Pharma Science Limited

Strides Pharma Science Limited (STAR) operates in the Healthcare sector, specifically as a Drug Manufacturer - Specialty & Generic. The company develops, manufactures, and sells ph...

हिन्दी में

स्ट्राइड्स फार्मा साइंस लिमिटेड (STAR) हेल्थकेयर सेक्टर में, विशेष रूप से एक स्पेशलिटी और जेनेरिक ड्रग मैन्युफैक्चरर के रूप में काम करती है। यह कंपनी फार्मास्यूटिकल उत्पादों का विक...

₹1,085.3-0.91%1D
Previous trading day close · Data updates after market close
1W: -0.1%
1M: -9.2%
6M: +8.4%
1Y: +30.5%
60/100
AverageResearch Score
Market Cap
₹9.9K Cr
Mid Cap
P/E Ratio
18.67
Below avg
P/B Ratio
4.02
Premium
ROE
154.3%
Strong
ROCE
25.4%
Excellent
Debt / Equity
0.73
Moderate
Div. Yield
0.4%
EV/EBITDA
11.52
Attractive
52W Low: ₹768.65Current: ₹1,085.352W High: ₹1,260.9
At 64% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
65/100
Growth
Revenue, EPS, profit growth
54/100
Valuation
PE, PB, EV/EBITDA vs sector
66/100
Risk
Debt levels, volatility, coverage
58/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
18.67(Below avg)
Forward P/E
16.53(Attractive)
P/B Ratio
4.02(Premium)
P/S Ratio
2.07(Good)
EV/EBITDA
11.52(Attractive)
Dividend Yield
0.4%
5Y CAGR
26.9%(High growth)
Revenue Growth
-36.8%(Moderate)
Profitability
ROE
154.3%(Excellent)
ROCE
25.4%(Excellent)
ROA
61.3%(Efficient)
Net Margin
11.1%(Decent)
EBITDA Margin
21.0%
Financial Health
Debt to Equity
0.73(Moderate)
Current Ratio
1.20(Tight)
Quick Ratio
0.70(Tight)
Interest Coverage
4.75x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
23(Oversold)
RSI Exp (14)
21(Oversold)
MACD
-2.026(Bearish)
MACD Signal
14.472
BB Position
16%(Lower band)
BB Width
18.76%(Normal)
ADX (14)
41.5(Strong trend)
Williams %R
-90.6(Oversold)
MFI (14)
31(Neutral)
CCI (20)
-110(Oversold)
Stoch %K
9(Oversold)
ATR (14)
38.71(Avg True Range)
OBV (M)
48.8(Positive)
1W OBV Chg
-0.3%(Decreasing)
Rel Volume
0.51x(Normal)
Volatility
58.3%(High)
Max DD 1Y
-65.3%(High loss)
EMA 200
1029.3
EMA 50
1103.0
SMA 200
1012.4
vs SMA 50
0.8%(Above SMA50)
vs SMA 200
7.2%(Above SMA200)
Volume
1.89L
Avg Vol 3M
3.7L
Shareholding Pattern
Promoter
27.9%
Low stake
FII
28.7%
Strong foreign interest
DII / MF
14.4%
Share STAR
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.